|
1
|
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography.
|
Circulation
|
2002
|
4.43
|
|
2
|
The Concise Guide to PHARMACOLOGY 2013/14: overview.
|
Br J Pharmacol
|
2013
|
2.48
|
|
3
|
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.
|
Br J Pharmacol
|
2000
|
1.78
|
|
4
|
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium.
|
Circ Res
|
1993
|
1.56
|
|
5
|
ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.
|
Br J Pharmacol
|
1995
|
1.48
|
|
6
|
[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man.
|
Br J Pharmacol
|
2001
|
1.40
|
|
7
|
Chemokine receptor CCR5: from AIDS to atherosclerosis.
|
Br J Pharmacol
|
2011
|
1.29
|
|
8
|
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
|
Kidney Int
|
1993
|
1.22
|
|
9
|
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart.
|
Br J Pharmacol
|
1992
|
1.17
|
|
10
|
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
|
Br J Pharmacol
|
1994
|
1.15
|
|
11
|
Endothelin-1 mRNA is widely expressed in porcine and human tissues.
|
J Clin Invest
|
1990
|
1.13
|
|
12
|
[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis.
|
Br J Pharmacol
|
2001
|
1.11
|
|
13
|
Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.
|
Br J Pharmacol
|
2007
|
1.11
|
|
14
|
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats.
|
Br J Pharmacol
|
2001
|
1.10
|
|
15
|
Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta.
|
Circ Res
|
1996
|
1.04
|
|
16
|
Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro.
|
Br J Pharmacol
|
1994
|
1.01
|
|
17
|
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1.
|
Am J Physiol Regul Integr Comp Physiol
|
2001
|
1.00
|
|
18
|
Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.
|
J Clin Endocrinol Metab
|
1992
|
1.00
|
|
19
|
Secretory pathways in endothelin synthesis.
|
Br J Pharmacol
|
1999
|
0.98
|
|
20
|
Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme.
|
Circ Res
|
1998
|
0.97
|
|
21
|
Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue.
|
J Hypertens
|
1992
|
0.95
|
|
22
|
Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin.
|
J Cardiovasc Pharmacol
|
1998
|
0.95
|
|
23
|
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan.
|
Br J Pharmacol
|
2001
|
0.93
|
|
24
|
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.
|
Br J Pharmacol
|
2009
|
0.93
|
|
25
|
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.
|
Atherosclerosis
|
2009
|
0.93
|
|
26
|
Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors.
|
Br J Clin Pharmacol
|
1998
|
0.93
|
|
27
|
Endothelin receptors in human coronary artery and aorta.
|
Br J Pharmacol
|
1996
|
0.92
|
|
28
|
Endothelin converting enzyme (ECE) activity in human vascular smooth muscle.
|
Br J Pharmacol
|
1997
|
0.90
|
|
29
|
Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells.
|
Br J Pharmacol
|
1995
|
0.89
|
|
30
|
Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
|
Br J Pharmacol
|
1996
|
0.89
|
|
31
|
Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery.
|
Br J Pharmacol
|
2001
|
0.89
|
|
32
|
Endothelin receptor subtypes and their functional relevance in human small coronary arteries.
|
Br J Pharmacol
|
1998
|
0.89
|
|
33
|
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044.
|
Br J Pharmacol
|
1996
|
0.89
|
|
34
|
Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution.
|
Biochem Biophys Res Commun
|
1993
|
0.88
|
|
35
|
Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1.
|
Can J Physiol Pharmacol
|
2010
|
0.88
|
|
36
|
Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells.
|
Circ Res
|
1999
|
0.88
|
|
37
|
Endothelin receptor antagonism in patients with chronic heart failure.
|
Cardiovasc Res
|
2000
|
0.87
|
|
38
|
Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated.
|
J Cardiovasc Pharmacol
|
1993
|
0.87
|
|
39
|
Blockade and reversal of endothelin-induced constriction in pial arteries from human brain.
|
Stroke
|
1999
|
0.87
|
|
40
|
A quantitative 'in-situ' hybridization method using computer-assisted image analysis. Validation and measurement of atrial-natriuretic-factor mRNA in the rat heart.
|
Biochem J
|
1989
|
0.87
|
|
41
|
Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system.
|
Br J Pharmacol
|
2001
|
0.87
|
|
42
|
Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments.
|
Br J Pharmacol
|
1996
|
0.86
|
|
43
|
Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.
|
Br J Pharmacol
|
1995
|
0.86
|
|
44
|
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
|
Br J Pharmacol
|
2001
|
0.86
|
|
45
|
Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors.
|
J Pharmacol Exp Ther
|
1997
|
0.86
|
|
46
|
Expression of endothelin peptides and mRNA in the human heart.
|
Clin Sci (Lond)
|
1996
|
0.85
|
|
47
|
Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12.
|
Br J Pharmacol
|
2014
|
0.85
|
|
48
|
Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
|
Br J Pharmacol
|
1996
|
0.85
|
|
49
|
Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells.
|
Br J Pharmacol
|
1995
|
0.85
|
|
50
|
Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.
|
Can J Physiol Pharmacol
|
2002
|
0.85
|
|
51
|
Localization of endothelin receptors in human uterus throughout the menstrual cycle.
|
Mol Hum Reprod
|
1996
|
0.84
|
|
52
|
Localization of endothelin peptides in human kidney.
|
Kidney Int
|
1996
|
0.84
|
|
53
|
Quantification of mRNA in human tissue using fluorescent nested reverse-transcriptase polymerase chain reaction.
|
Anal Biochem
|
1994
|
0.84
|
|
54
|
Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues.
|
Hum Reprod
|
1991
|
0.84
|
|
55
|
Endothelin receptor expression and pharmacology in human saphenous vein graft.
|
Br J Pharmacol
|
1999
|
0.84
|
|
56
|
Endothelin expression in the uterus.
|
J Steroid Biochem Mol Biol
|
1995
|
0.84
|
|
57
|
Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas.
|
J Cardiovasc Pharmacol
|
1995
|
0.83
|
|
58
|
Endothelin: progress in pharmacology and physiology.
|
Trends Pharmacol Sci
|
1993
|
0.83
|
|
59
|
Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm.
|
Br J Pharmacol
|
1995
|
0.83
|
|
60
|
Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707.
|
Neurosurgery
|
1998
|
0.83
|
|
61
|
Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain.
|
J Cardiovasc Pharmacol
|
1998
|
0.82
|
|
62
|
Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies.
|
Placenta
|
1997
|
0.82
|
|
63
|
Human kidney: endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020.
|
J Cardiovasc Pharmacol
|
1993
|
0.82
|
|
64
|
Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays.
|
Clin Sci (Lond)
|
1994
|
0.82
|
|
65
|
Regulation of endothelin receptor expression in vascular smooth-muscle cells.
|
J Cardiovasc Pharmacol
|
1995
|
0.81
|
|
66
|
Localization of immunoreactive endothelin and proendothelin in the human lung.
|
Pulm Pharmacol
|
1992
|
0.81
|
|
67
|
Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries.
|
Placenta
|
2003
|
0.81
|
|
68
|
Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors.
|
J Hypertens
|
1994
|
0.81
|
|
69
|
Endothelin-A-receptors in human aorta and pulmonary arteries are downregulated in patients with cardiovascular disease: an adaptive response to increased levels of endothelin-1?
|
J Cardiovasc Pharmacol
|
2000
|
0.81
|
|
70
|
Endothelin-like immunoreactivity in human endometrium.
|
J Reprod Fertil
|
1992
|
0.81
|
|
71
|
ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
|
J Endocrinol
|
1995
|
0.81
|
|
72
|
Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease.
|
Br J Pharmacol
|
1998
|
0.80
|
|
73
|
Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium.
|
J Reprod Fertil
|
1993
|
0.80
|
|
74
|
Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation.
|
Br J Pharmacol
|
2006
|
0.80
|
|
75
|
No alteration in vasoconstrictor endothelin-B-receptor density or function in human coronary artery disease.
|
J Cardiovasc Pharmacol
|
2000
|
0.79
|
|
76
|
The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells.
|
Atherosclerosis
|
1990
|
0.79
|
|
77
|
Delineation of endothelin receptors in human left ventricular smooth-muscle cells.
|
J Cardiovasc Pharmacol
|
1995
|
0.78
|
|
78
|
Endothelin-2 mRNA splice variants detected by RT-PCR in cultured human vascular smooth muscle and endothelial cells.
|
J Cardiovasc Pharmacol
|
1993
|
0.78
|
|
79
|
Changes in ET(A)-, AT1- and AT2-receptors in the phenotypically transformed intimal smooth muscle layer of human atherosclerotic coronary arteries.
|
J Cardiovasc Pharmacol
|
2000
|
0.78
|
|
80
|
Localization and endogenous concentration of endothelin-like immunoreactivity in human placenta.
|
J Endocrinol
|
1991
|
0.78
|
|
81
|
Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans.
|
J Cardiovasc Pharmacol
|
1995
|
0.78
|
|
82
|
Endothelin peptide and converting enzymes in human endothelium.
|
J Cardiovasc Pharmacol
|
1998
|
0.77
|
|
83
|
Novel nitric oxide donors reverse endothelin-1-mediated constriction in human blood vessels.
|
J Cardiovasc Pharmacol
|
2000
|
0.77
|
|
84
|
PD156707: a potent antagonist of endothelin-1 in human diseased coronary arteries and vein grafts.
|
J Cardiovasc Pharmacol
|
1998
|
0.77
|
|
85
|
Distribution of endothelin receptors in atherosclerotic human coronary arteries.
|
J Cardiovasc Pharmacol
|
1995
|
0.77
|
|
86
|
Biogenic amines in the brain of the honeybee, Apis mellifera.
|
Cell Tissue Res
|
1983
|
0.77
|
|
87
|
Syntheses of the first endothelin-A- and -B-selective radioligands for positron emission tomography.
|
J Cardiovasc Pharmacol
|
2000
|
0.77
|
|
88
|
Endothelin and the human kidney: a potential target for new drugs.
|
Nephrol Dial Transplant
|
1994
|
0.77
|
|
89
|
Comparative quantification of endothelin receptor mRNA in human kidney: new tools for direct investigation of human tissue.
|
J Cardiovasc Pharmacol
|
1995
|
0.76
|
|
90
|
Atrial natriuretic factor mRNA and binding sites in the adrenal gland.
|
Biochem J
|
1990
|
0.76
|
|
91
|
Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB209670, and 97-139.
|
J Cardiovasc Pharmacol
|
1995
|
0.76
|
|
92
|
In vitro enzymatic processing of radiolabelled big ET-1 in human kidney.
|
Biochem Pharmacol
|
1998
|
0.76
|
|
93
|
Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b.
|
Brain Res
|
1992
|
0.76
|
|
94
|
The haemodynamic effects of iodinated water soluble radiographic contrast media: a review.
|
Eur J Radiol
|
1998
|
0.76
|
|
95
|
Characterization of peptide and nonpeptide antagonists in human kidney.
|
J Cardiovasc Pharmacol
|
1995
|
0.76
|
|
96
|
Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography.
|
J Cardiovasc Pharmacol
|
1997
|
0.76
|
|
97
|
Endothelin-1 stimulates prostaglandin F2 alpha release from human endometrium.
|
Prostaglandins Leukot Essent Fatty Acids
|
1991
|
0.76
|
|
98
|
Characterization of site-directed antisera against endothelin-converting enzymes.
|
J Cardiovasc Pharmacol
|
1998
|
0.75
|
|
99
|
Autoradiographic study of endothelin receptors in human cerebral arteries.
|
J Cardiovasc Pharmacol
|
1995
|
0.75
|
|
100
|
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
|
Neuroscience
|
1988
|
0.75
|
|
101
|
Tissue-specific modulation of endothelin receptors in a rat model of hypertension.
|
J Cardiovasc Pharmacol
|
2000
|
0.75
|
|
102
|
Molecular aspects of atrial natriuretic factor physiology.
|
Ann Acad Med Singapore
|
1991
|
0.75
|
|
103
|
Quantitative autoradiography reveals higher densities of specific calcitonin-gene-related peptide receptors in small intramyocardial compared with large epicardial coronary arteries.
|
Clin Sci (Lond)
|
1993
|
0.75
|
|
104
|
Selective downregulation of ETA receptor mRNA in renal transplant recipients on cyclosporin A revealed by quantitative RT-PCR.
|
Nephrol Dial Transplant
|
1996
|
0.75
|
|
105
|
Expression and characterization of the human endothelin-A-receptor in Pichia pastoris: influence of N-terminal epitope tags.
|
J Cardiovasc Pharmacol
|
2000
|
0.75
|
|
106
|
Sex-related differences in the concentration of Met-enkephalin-like immunoreactivity in the nervous system of an insect, Schistocerca gregaria, revealed by radioimmunoassay.
|
Brain Res
|
1986
|
0.75
|
|
107
|
Potency of PD155080, an orally active ETA receptor antagonist, determined for human endothelin receptors.
|
J Cardiovasc Pharmacol
|
1995
|
0.75
|
|
108
|
Quantitative analysis of autoradiograms.
|
Experientia Suppl
|
1989
|
0.75
|
|
109
|
Analysis of endogenous human endothelin peptides by high-performance liquid chromatography and mass spectrometry.
|
J Cardiovasc Pharmacol
|
1995
|
0.75
|
|
110
|
The therapeutic potential of PD156707 and related butenolide endothelin antagonists.
|
Expert Opin Investig Drugs
|
1999
|
0.75
|
|
111
|
Isolation of human cardiac endothelin receptors by a peptide-receptor mobility shift assay.
|
Clin Sci (Lond)
|
1993
|
0.75
|